top of page

Agneta Edberg
Founder & Chairman

A.E.png

Professional Experience 

Agneta has more than 25 years experience from leading management positions in big pharma companies like Orion Pharma, Pharmacia, Pfizer, and Mylan in different roles being responsible for clinical development, business development as well as country management. Agnetas roles have developed from Sales and Product management, Regulatory affairs, Business director, Clinical Trials Unit Manager, COO, CEO to Nordic Senior Vice President. Agneta has been a member of the board in +20 companies. Whereof +10 as chairman. Involved in three IPOs. She has also worked as Senior Venture Manager in a specialist life science investment company. Today, Agneta works as a chairman in Elicera Therapeutics, CathPrint, Amferia and the Association of ATMP Sweden. She is also active as a board member in a Swedish governmental funded project for ATMP cross functional networking called CAMP, working with academia, hospitals, SME and big pharma to create a favorable implementation milieu to the benefit of the patients as well as the NextGenNK, a Competence Center for the development of next generation NK cell-based cancer immunotherapies coordinated by Karolinska Institutet.

Education

BMA clinical chemistry, Högskolan Sundsvall, Sweden; Microbiology, Umeå University, Sweden; Health Economics, Stockholm School of Economics, Sweden. Also Extensive GXP training; Market Communication as well as Nasdaq trainings for listed companies. 

bottom of page